adalimumab biosimilar
/ Arecor
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 09, 2022
Arecor granted European patents to protect Humira formulations
(PharmaTimes)
- "Arecor Therapeutics has announced that the European Patent Office has granted two patents –EP3592383B1 and EP3592385B1 – protecting the group’s novel formulations of high-concentration adalimumab until 2038."
Patent • Immunology • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1